Charleston, SC -- (SBWIRE) -- 09/04/2013 -- ImpressivePennyStocks.com covers several stocks on the NASDAQ and New York Stock Exchange that technically qualify as penny stocks, we typically find ones that are on the OTC Market. ImpressivePennyStocks.com issues a special report on the following stocks: OmniVision Technologies, Inc. (NASDAQ:OVTI), Novavax, Inc. (NASDAQ:NVAX), Halozyme Therapeutics, Inc. (NASDAQ:HALO), Nuverra Environmental Solutions Inc (NYSE:NES).
OmniVision Technologies, Inc. (NASDAQ:OVTI) remained among the day decliners and traded with volume of 3,521,790 shares in the last session, as compared to average volume of 1.44 million shares. The stock on Tuesday decreased -0.61% and finished the day at $15.35. The 52 week range of the stock remained $12.06 - $20.48. OmniVision Technologies, Inc. engages in designing, developing, and marketing semiconductor image-sensor devices worldwide. It offers CameraChip image sensors, which are single-chip solutions that integrate various functions.
Has OVTI Found The Bottom and Ready To Move Up? Find Out Here
Novavax, Inc. (NASDAQ:NVAX) remained among day gainers during the previous trading session, opened at the price of $3.22, whereas its previous closing price was recorded at $3.20. Total volume of the stock was 3,518,799 shares during last trade, while its average volume is 2.87 million shares. Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases. The company’s technology platform is based on proprietary recombinant vaccine technology that includes virus-like particles (VLPs) and recombinant protein micelle vaccines.
For How Long NVAX’s Gloss will Attract Investors? Find out via this report
Halozyme Therapeutics, Inc. (NASDAQ:HALO) reported an upsurge during previous trade, ended its day with the gain of 2.89% and closed at the price of $8.55, after opening at $8.90. Stock exchanged hands during its last trading session with the total volume of 3,445,390 shares, as compared to its average volume of 1.45 million shares. Halozyme Therapeutics, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human enzymes. Its research focuses on human enzymes that transiently modify tissue under the skin to facilitate the delivery of injected drugs and fluids, or to alter abnormal tissue structures for clinical benefit.
Will HALO Continue To Move Higher? Find Out Here
Nuverra Environmental Solutions Inc (NYSE:NES) was showing an upward trend during the previous trading session, reported the increase of 5.22%, to close at $2.42, with the overall traded volume of 3,402,635 shares. During last trade, the company’s minimum price was $2.34, while it touched its highest price of $2.47. Nuverra Environmental Solutions, Inc., an environmental solutions company, provides full-cycle environmental solutions to customers in energy and industrial end-markets in the United States.
Why Should Investors Buy NES After The Recent Gain? Just Go Here and Find Out
About Impressive Penny Stocks:
We are different here at Impressive Penny Stocks because we care about our subscribers. You can email us any time with questions, tips, or just to say hello. We are real people and we love to hear from our loyal subscribers.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list.
Never invest into a stock discussed on this web site or the ImpressivePennyStocks.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
ImpressivePennyStocks.com is owned and operated by FlipVentures LLC. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. ImpressivePennyStocks’s sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by ImpressivePennyStocks or an offer or solicitation to buy or sell any security. Neither the owner of ImpressivePennyStocks nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed in a release or on our website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. ImpressivePennyStocks makes no recommendation that the securities of the companies profiled or discussed in our releases or on our website should be purchased, sold or held by investors.
Read Full Disclaimer at: http://impressivepennystocks.com/disclaimer/#navigation
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)